EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+6.72%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(-2.3%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
61.23%
Holding
86
New
16
Increased
25
Reduced
27
Closed
12
Top Buys
| 1 |
Insmed
INSM
|
$77.4M |
| 2 |
Repligen
RGEN
|
$23.5M |
| 3 |
Inspire Medical Systems
INSP
|
$15M |
| 4 |
Novo Nordisk
NVO
|
$12.1M |
| 5 |
HCA Healthcare
HCA
|
$10.2M |
Top Sells
| 1 |
Natera
NTRA
|
$65.5M |
| 2 |
Pfizer
PFE
|
$30.6M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$26.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$21.2M |
| 5 |
Tenet Healthcare
THC
|
$18.5M |
Sector Composition
| 1 | Healthcare | 99.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Danaher
DHR
$147B
| $10.2M | 0.7% | 40,855 | – | – |
|
27
SPDR S&P Biotech ETF
XBI
$5.07B
| $9.27M | 0.63% | +100,000 | New | +$9.27M |
|
28
Travere Therapeutics
TVTX
$1.56B
| $8.97M | 0.61% | 1,091,165 +135,547 | +14% | +$1.11M |
|
29
Elevance Health
ELV
$71.8B
| $7.94M | 0.54% | 14,657 +264 | +2% | +$143K |
|
30
Arcutis Biotherapeutics
ARQT
$1.86B
| $7.79M | 0.53% | +837,847 | New | +$7.79M |
|
31
Centene
CNC
$14.3B
| $7.68M | 0.53% | 115,820 +23,034 | +25% | +$1.53M |
|
32
Viridian Therapeutics
VRDN
$1.5B
| $7.38M | 0.51% | 567,487 +425,412 | +299% | +$5.53M |
|
33
Viking Therapeutics
VKTX
$3.04B
| $7.34M | 0.5% | 138,489 +115,671 | +507% | +$6.13M |
|
34
Vaxcyte
PCVX
$4B
| $7.26M | 0.5% | 96,089 -101,242 | -51% | -$7.64M |
|
35
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.12M | 0.49% | 1,152,573 -279,854 | -20% | -$1.73M |
|
36
Cytokinetics
CYTK
$4.23B
| $6.87M | 0.47% | +126,877 | New | +$6.87M |
|
37
NewAmsterdam Pharma
NAMS
$2.71B
| $6.34M | 0.43% | 329,890 -24,075 | -7% | -$462K |
|
38
Evolus
EOLS
$494M
| $6.23M | 0.43% | +574,462 | New | +$6.23M |
|
39
Molina Healthcare
MOH
$9.8B
| $5.43M | 0.37% | 18,277 +12,449 | +214% | +$3.7M |
|
40
Sutro Biopharma
STRO
$72.7M
| $5.1M | 0.35% | 1,739,129 +647,710 | +59% | +$1.9M |
|
41
Gossamer Bio
GOSS
$562M
| $4.94M | 0.34% | 5,484,148 -510,324 | -9% | -$460K |
|
42
Oscar Health
OSCR
$4.31B
| $4.92M | 0.34% | +310,893 | New | +$4.92M |
|
|
CERE
43
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.5M | 0.31% | +110,010 | New | +$4.5M |
|
44
Liquidia Corp
LQDA
$2.38B
| $4.48M | 0.31% | 373,554 -22,633 | -6% | -$272K |
|
45
Myriad Genetics
MYGN
$593M
| $4.45M | 0.3% | +181,961 | New | +$4.45M |
|
46
Puma Biotechnology
PBYI
$254M
| $4.33M | 0.3% | 1,328,454 -98,043 | -7% | -$320K |
|
47
Karyopharm Therapeutics
KPTI
$61.7M
| $4.33M | 0.3% | 4,987,180 -29,140 | -0.6% | -$25.3K |
|
|
TSVT
48
DELISTED
2seventy bio
TSVT
| $4.26M | 0.29% | 1,107,743 -69,935 | -6% | -$269K |
|
|
NVRO
49
DELISTED
NEVRO CORP.
NVRO
| $4.2M | 0.29% | 499,395 +109,732 | +28% | +$924K |
|
50
Icon
ICLR
$13.8B
| $3.96M | 0.27% | 12,642 -2,705 | -18% | -$848K |
|